Cartilage and serum levels of nitric oxide in patients with hip osteoarthritis
Salvatierra, J.; Escames, G.; Hernandez, P.; Cantero, J.; Crespo, E.; Leon, J.; Salvatierra, D.; Acuña-Castroviejo, D.; Vives, F.
Journal of Rheumatology 26(9): 2015-2017
1999
ISSN/ISBN: 0315-162X PMID: 10493684 Document Number: 509013
Objective. To assess whether nitric oxide (NO) is related to cartilage deterioration resulting from osteoarthritis NO concentrations were analyzed in normal and deteriorated areas of cartilage obtained from femur heads of patients with primary hip osteoarthritis (HOA). Methods. The concentration of NO in macroscopically deteriorated and non-deteriorated cartilage of femoral heads of patients with HOA at hip replacement surgery was analyzed spectrophotometrically. Serum NO levels were also determined in 16 ambulatory patients with hip OA and in healthy volunteers. Results. NO levels of non-deteriorated areas of femoral head cartilage were significantly lower (3.82 +- 1.30 mumol/l; mean +-SD) than levels of deteriorated cartilage areas (11.07 +- 6.48 mumol/l; p < 0.01). The surgery HOA group showed serum NO levels (2.64 +- 0.32 mumol/l; p < 0.0001 vs healthy group) similar to the ambulatory HOA group levels (2.56 +- 0.56 mumol/l; p < 0.0001 vs healthy group). Serum NO concentrations in healthy volunteers were 1.37 +- 0.55 mumol/l. Conclusion. This study shows increased NO levels in joint cartilage of patients with hip OA. This increase was not homogeneously distributed but the higher NO levels were found in macroscopically deteriorated areas. The data also suggest that high NO serum levels found in patients with hip OA may be due to joint cartilage destruction.